Analyst Price Targets — CPSH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 13, 2025 9:30 am | — | Roth Capital | $6.00 | $3.30 | TheFly | CPS Technologies initiated with a Buy at Roth Capital |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CPSH

Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Purepoint Uranium Group Inc. (TSXV: PTU) (OTCQB: PTUUF) ("Purepoint") reports that the nine holes of its winter 2026 drill program at the Nova Discovery have been successful in extending the uranium mineralization and favourable geology at the Dorado Joint Venture Project ("Dorado" or the "Project"), located in Saskatchewan's Athabasca Basin. Purepoint, as…

LAS VEGAS, Nevada, April 06, 2026 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that on April 3, 2026, it amended its two-year revolving credit agreement with Capital One, N.A. to increase the capacity of the facility.

Shares of CPS Technologies Corp. (NASDAQ: CPSH - Get Free Report) passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $3.94 and traded as low as $3.81. CPS Technologies shares last traded at $4.02, with a volume of 85,871 shares. Wall Street Analyst Weigh In Several

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that KEYTRUDA® (pembrolizumab), in combination with paclitaxel, with or without bevacizumab, is approved in the European Union (EU) for the treatment of platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal carcinoma in adults whose tumors express PD-L1 with a Combined…

ABCO Energy (OTCMKTS:ABCE - Get Free Report) and CPS Technologies (NASDAQ: CPSH - Get Free Report) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation. Institutional and Insider Ownership 11.2% of
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CPSH.
U.S. House Trading
No House trades found for CPSH.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
